Log in to save to my catalogue

Feasibility, safety, and impact of the RTS,S/AS01 E malaria vaccine when implemented through nationa...

Feasibility, safety, and impact of the RTS,S/AS01 E malaria vaccine when implemented through nationa...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3046381051

Feasibility, safety, and impact of the RTS,S/AS01 E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi

About this item

Full title

Feasibility, safety, and impact of the RTS,S/AS01 E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi

Publisher

England: Elsevier Limited

Journal title

The Lancet (British edition), 2024-04, Vol.403 (10437), p.1660

Language

English

Formats

Publication information

Publisher

England: Elsevier Limited

More information

Scope and Contents

Contents

The RTS,S/AS01
malaria vaccine (RTS,S) was introduced by national immunisation programmes in Ghana, Kenya, and Malawi in 2019 in large-scale pilot schemes. We aimed to address questions about feasibility and impact, and to assess safety signals that had been observed in the phase 3 trial that included an excess of meningitis and cerebral malaria...

Alternative Titles

Full title

Feasibility, safety, and impact of the RTS,S/AS01 E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_3046381051

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3046381051

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(24)00004-7

How to access this item